Proof-of-concept study of two targeted phage-based vaccination approaches against SARS-CoV-2 July 30, 2021
Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC July 29, 2021
New phase Ib/II trial evaluates pembrolizumab combination therapies in second-line ES-SCLC July 29, 2021
RSS